The Value of Contrast-enhanced Ultrasound in the Differentiation between Liver Metastases from Neuroendocrine Tumors and From Non-neuroendocrine Tumors

Hantao Wang,Wenping Wang,Xiaolong Zhang,Qing Lu,Hong Ding,Yadan Xu,Yi Dong
DOI: https://doi.org/10.3969/j.issn.1002-0101.2017.11.007
2017-01-01
Abstract:Objective To investigate the value of contrast-enhanced ultrasound (CEUS) in differentiation between liver metastases from neuroendocrine tumors(NETLM) and liver metastases from non-neuroendocrine tumors (NNETLM).Methods A total of 30 cases with NETLM and 50 cases with NNETLM were retrospectively studied with CEUS.The dynamic enhancement features,including enhancement time,enhancement pattern and washout pattern were observed.Results After injecting contrast agent,two groups of liver metastases lesions were variously enhanced on CEUS.The time of reducing enhancement (44.73±22.70) s in NETLM was later than that(33.72 ± 7.17) s in NNETLM (P<0.05).Two patterns of enhancement were observed during the arterial phase:global enhancement and rim-like enhancement.NETLM had a significantly higher proportion(93.3%) of global enhancement than that (56.0%) of NNETLM (P<0.05).These two groups lesions showed mild washout or remarkable washout in portal phase compared with liver parenchyma.NETLM had a significantly higher proportion(30.0%) of mild washout than that (4.0%) of NNETLM (P<0.05).Conclusions CEUS is useful for the differential diagnosis of NETLM and NNETLM.
What problem does this paper attempt to address?